Profile
Jay C.
Strum is the founder of Incyclix Bio LLC, founded in 2020, where the title held is Chief Scientific Officer.
Former jobs include Director-Genomics Division at GSK Plc from 1995 to 2009, Manager-Cell Technology Group at GlaxoSmithKline LLC from 1995 to 2009, and Chief Scientific Officer at G1 Therapeutics, Inc. from 2009 to 2020.
Education history includes a doctorate from Wake Forest University conferred in 1993 and an undergraduate degree from Western Carolina University conferred in 1987.
Jay Strum active positions
| Companies | Position | Start |
|---|---|---|
Incyclix Bio LLC
Incyclix Bio LLC BiotechnologyHealth Technology Develops CDK inhibitors for cancer patients | Founder | 2020-04-30 |
Former positions of Jay Strum
| Companies | Position | End |
|---|---|---|
| G1 THERAPEUTICS, INC. | President | - |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 2009-01-31 |
| GSK PLC | Corporate Officer/Principal | 2009-01-31 |
Training of Jay Strum
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Carolina University
Western Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Incyclix Bio LLC
Incyclix Bio LLC BiotechnologyHealth Technology Develops CDK inhibitors for cancer patients | Health Technology |
- Stock Market
- Insiders
- Jay Strum
















